US Stock MarketDetailed Quotes

GILD Gilead Sciences

Watchlist
  • 111.800
  • +0.640+0.58%
Trading Mar 28 13:43 ET
139.23BMarket Cap294.21P/E (TTM)

About Gilead Sciences Company

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Company Profile

SymbolGILD
Company NameGilead Sciences
Listing DateJan 22, 1992
Issue Price15.00
Founded1987
CEOMr. Daniel P. O'Day
MarketNASDAQ
Employees17600
Fiscal Year Ends12-31
Address333 Lakeside Drive
CityFoster City
ProvinceCalifornia
CountryUnited States of America
Zip Code94404
Phone1-650-574-3000

Company Executives

  • Name
  • Position
  • Salary
  • Daniel P. O'Day
  • Chairman of the Board and Chief Executive Officer
  • 22.61M
  • Johanna Mercier
  • Chief Commercial Officer
  • 8.59M
  • Andrew D. Dickinson
  • Chief Financial Officer
  • 8.11M
  • Dr. Dietmar Berger, M.D.,PhD
  • Chief Medical Officer
  • --
  • Diane E. Wilfong
  • Interim Corporate Controller and Interim Chief Accounting Officer
  • --
  • Deborah H. Telman
  • Executive Vice President, Corporate Affairs and General Counsel
  • 5.27M
  • Dr. Ted W. Love, M.D.
  • Director
  • --
  • Kelly Anne Kramer
  • Independent Director
  • 434.92K
  • Jeffrey A. Bluestone
  • Independent Director
  • 409.92K
  • Javier J. Rodriguez
  • Independent Director
  • 399.92K
  • Harish Manwani
  • Independent Director
  • 414.92K
  • Anthony Welters
  • Lead Independent Director
  • 444.92K
  • Dr. Sandra J. Horning, M.D.
  • Independent Director
  • 429.92K
  • Dr. Jacqueline K. Barton, PhD
  • Independent Director
  • 429.92K
Market Insights
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.